← Browse by Condition
Medical Condition

systemic sclerosis associated interstitial lung disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT05878717 Phase 2, Phase 3
Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Enrollment
300 pts
Location
United States, Argen...
Sponsor
GlaxoSmithKline
View Trial →